Meet Fluicell in July

July comes with several opportunities to meet with Fluicell and discuss everything from single-cell biology and bioprinting to…

Read more
28 Jun 2021

Fluicell welcomes Niek Welkenhuysen

Fluicell welcomes Niek Welkenhuysen who started with us in May as a development engineer. Although Niek recently joined…

Read more
14 Jun 2021

BioPen Nanoparticle Delivery

We have just released a new application example for BioPen®, covering nanoparticle delivery for single-cell biology. Using Fluicell’s…

Read more
10 Jun 2021

Fluicell CEO Newsletter 04, 2021

The announcement of the BioRej™ Advance program for regenerative medicine partnerships in the beginning of May was the…

Read more
01 Jun 2021

Fluicell welcomes Sandra Tejedor

Sandra Tejedor, who recently finished her PhD at University of Valencia, now joins Fluicell as an Application Scientist,…

Read more
18 May 2021

Fluicell enters into the world of regenerative medicine

Today, Fluicell takes a big step forward in the development of the company. Based on Biopixlar’s unique high-resolution…

Read more
07 May 2021

Researchers develop antibodies targeting ion channel hTRPV1, important for pain therapy

In a research article, published on April 16 in Science Advances, researchers from Oblique Therapeutics AB together with…

Read more
19 Apr 2021

Årsstämma 2021

English version follows below. Med anledning av den fortsatta smittspridningen av viruset som orsakar covid-19 kommer Fluicells årsstämma…

Read more
16 Apr 2021

CEO Newsletter 3, 2021

”Retreading old footsteps has never been a driving force for Fluicell” In the third issue of the CEO…

Read more
30 Mar 2021